Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?
Top Cited Papers
- 17 July 2022
- journal article
- other
- Published by Taylor & Francis in Expert Opinion on Biological Therapy
- Vol. 22 (10) , 1275-1291
Abstract
Diabetic retinopathy (DR) is one of the most frequent microvascular complications of diabetes that can lead to blindness. Laser treatment has been the gold standard treatment for diabetic macular e...Keywords
This publication has 102 references indexed in Scilit:
- A 2-Year Prospective Randomized Controlled Trial of Intravitreal Bevacizumab or Laser Therapy (BOLT) in the Management of Diabetic Macular EdemaArchives of Ophthalmology (1950), 2012
- An Outbreak of Streptococcus Endophthalmitis After Intravitreal Injection of BevacizumabAmerican Journal of Ophthalmology, 2012
- Expanded 2-Year Follow-up of Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2011
- Safety and Efficacy of Ranibizumab in Diabetic Macular Edema (RESOLVE Study)Diabetes Care, 2010
- Diabetic retinopathyThe Lancet, 2010
- Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular EdemaOphthalmology, 2010
- Intravitreal Bevacizumab for the Treatment of Refractory Diabetic Macular EdemaOphthalmic Surgery, Lasers and Imaging Retina, 2010
- Primary End Point (Six Months) Results of the Ranibizumab for Edema of the mAcula in Diabetes (READ-2) StudyOphthalmology, 2009
- Progression of diabetic tractional retinal detachment following single injection of intravitreal AvastinEye, 2007
- A Phase II Randomized Clinical Trial of Intravitreal Bevacizumab for Diabetic Macular EdemaOphthalmology, 2007